Certis Oncology Solutions Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
39
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$10M
- Investors
-
1
Certis Oncology Solutions General Information
Description
Developer of oncology intelligence designed to connect patients to the optimal therapy for their cancer. The company offers predictive therapeutic response data derived from proprietary biological models of cancer, these models are applied to machine learning and AI-enhanced predictive algorithms, enabling oncologists to increase efficiency and decision-making speed in oncology research.
Contact Information
Website
www.certisoncology.comCorporate Office
- 5626 Oberlin Drive
- Suite 110
- San Diego, CA 92121
- United States
Corporate Office
- 5626 Oberlin Drive
- Suite 110
- San Diego, CA 92121
- United States
Certis Oncology Solutions Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC (Series C) | 17-Jan-2024 | $10M | Completed | Generating Revenue | ||
| 2. Early Stage VC (Series B) | 14-Apr-2020 | Completed | Generating Revenue | |||
| 1. Early Stage VC (Series A) | 14-Aug-2019 | $4.2M | $4.2M | Completed | Generating Revenue |
Certis Oncology Solutions Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Certis Oncology Solutions Comparisons
Industry
Financing
Details
Certis Oncology Solutions Competitors (36)
One of Certis Oncology Solutions’s 36 competitors is Mammoth Biosciences, a Venture Capital-Backed company based in Brisbane, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Mammoth Biosciences | Venture Capital-Backed | Brisbane, CA | ||||
| Perthera | Venture Capital-Backed | McLean, VA | ||||
| EdiGene | Venture Capital-Backed | Beijing, China | ||||
| Adaptimmune Therapeutics | Formerly VC-backed | Abingdon, United Kingdom | ||||
| Vir Biotechnology | Formerly VC-backed | San Francisco, CA |
Certis Oncology Solutions Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Certis Oncology Solutions Patents
Certis Oncology Solutions Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250295666-A1 | Pi3k-alpha inhibitor and mtor inhibitor combinations for cancer treatment | Inactive | 22-Mar-2024 | ||
| US-20250295667-A1 | Pi3k-alpha inhibitor and mtor inhibitor combinations for cancer treatment | Pending | 22-Mar-2024 | ||
| WO-2025199496-A1 | Pi3k-alpha inhibitor and mtor inhibitor combinations for cancer treatment | Pending | 22-Mar-2024 | ||
| GB-2643817-A | Artificial intelligence for identifying one or more predictive biomakers | Pending | 23-Mar-2023 | ||
| AU-2024238433-A1 | Artificial intelligence for identifying one or more predictive biomarkers | Pending | 23-Mar-2023 | G16H50/20 |
Certis Oncology Solutions Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Certis Oncology Solutions Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Incite Ventures (San Francisco) | Venture Capital | Minority |
Certis Oncology Solutions FAQs
-
When was Certis Oncology Solutions founded?
Certis Oncology Solutions was founded in 2016.
-
Where is Certis Oncology Solutions headquartered?
Certis Oncology Solutions is headquartered in San Diego, CA.
-
What is the size of Certis Oncology Solutions?
Certis Oncology Solutions has 39 total employees.
-
What industry is Certis Oncology Solutions in?
Certis Oncology Solutions’s primary industry is Drug Discovery.
-
Is Certis Oncology Solutions a private or public company?
Certis Oncology Solutions is a Private company.
-
What is Certis Oncology Solutions’s current revenue?
The current revenue for Certis Oncology Solutions is .
-
How much funding has Certis Oncology Solutions raised over time?
Certis Oncology Solutions has raised $46.2M.
-
Who are Certis Oncology Solutions’s investors?
Incite Ventures (San Francisco) has invested in Certis Oncology Solutions.
-
Who are Certis Oncology Solutions’s competitors?
Mammoth Biosciences, Perthera, EdiGene, Adaptimmune Therapeutics, and Vir Biotechnology are some of the 36 competitors of Certis Oncology Solutions.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
